Nature of business, basis of presentation and summary of significant accounting policies (10K) (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

The Company’s cash and cash equivalents, at December 31, consisted of the following:

	2014		2013
Cash in bank	$	775	$	945
Money market funds		—		—
Cash and cash equivalents	$	775	$	945

Schedule of amortization for intangible assets

Future intangible asset amortization is as follows:

Year Ended December 31,
2015	$	342
2016		323
2017		268
Total	$	933

Schedule of Antidilutive Securities Excluded from Calculation of Earnings Per Share

The following table lists shares and warrants that were excluded from the calculation of dilutive earnings per share as the exercise of such options and warrants and the conversion of such preferred shares would be anti-dilutive:

	For the Nine Months Ended
	September 30, 2015		September 30, 2014
Stock options		85		57
Warrants		190		137
Preferred shares as if converted
Series A-1 Preferred Stock		6,633		7,818
Series B Preferred Stock		304,430		275,888
Series C Preferred Stock		238,056		215,668
Series D-1 Preferred Stock		350,127		251,435
Series D-2 Preferred Stock		124,470		112,737

The number of shares of common stock subject to outstanding options, preferred shares on an as converted basis and shares issuable upon exercise of warrants excluded from the calculation of loss per share as their inclusion would be anti-dilutive are as follows:

	December 31, 2014		December 31, 2013
Common Stock subject to outstanding options		58		56
Series A-1 Preferred Stock		6,252		7,368
Series B Preferred Stock		282,750		256,241
Series C Preferred Stock		221,104		200,354
Series D-1 Preferred Stock		257,773		151,766
Series D-2 Preferred Stock		114,400		95,682
Warrants outstanding		171		62